Arjun Bhadhuri

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Journal of medical economics

PharmacoEconomics - open

Health and quality of life outcomes

PharmacoEconomics

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea Favre-Bulle, Goran Bencina, Shujing Zhang, Ruixuan Jiang, Daniel Andritschke, Arjun Bhadhuri
Cost-effectiveness of pembrolizumab as an adjuvant treatment for patients with resected stage IIB or IIC melanoma in Switzerland. Journal of medical economics (2023)
Andrea Favre-Bulle, Goran Bencina, Shujing Zhang, Ruixuan Jiang, Daniel Andritschke, Arjun Bhadhuri
Cost-effectiveness of pembrolizumab as an adjuvant treatment for patients with resected stage IIB or IIC melanoma in Switzerland. Journal of medical economics (2023)
Andrea Favre-Bulle, Min Huang, Amin Haiderali, Arjun Bhadhuri
Cost-Effectiveness of Neoadjuvant Pembrolizumab plus Chemotherapy Followed by Adjuvant Pembrolizumab in Patients with High-Risk, Early-Stage, Triple-Negative Breast Cancer in Switzerland. PharmacoEconomics - open (2023)
Andrea Favre-Bulle, Goran Bencina, Shujing Zhang, Ruixuan Jiang, Daniel Andritschke, Arjun Bhadhuri
Cost-effectiveness of pembrolizumab as an adjuvant treatment for patients with resected stage IIB or IIC melanoma in Switzerland. Journal of medical economics 26 (1) (2023)
Rebecca L Palmer, Munyaradzi Dimairo, Nicholas R Latimer, Elizabeth Cross, Marian C Brady, Pamela M Enderby, Audrey Bowen, Steven A Julious, Madeleine Harrison, Abualbishr Alshreef, Ellen Bradley, Arjun Bhadhuri, Timothy F Chater, Helen Hughes, Helen Witts, Esther Herbert, Cindy L Cooper
Computerised speech and language therapy or attention control added to usual care for people with long-term post-stroke aphasia: the Big CACTUS three-arm RCT. Health technology assessment (Winchester, England) 24 (19) (2021)
Nadine Schur, Kapil Gudala, Umakanth Vudumula, Sreelatha Vadapalle, Arjun Bhadhuri, Alain Casanova, Nicholas Adlard, Matthias Schwenkglenks
Cost Effectiveness and Budget Impact of Siponimod Compared to Interferon Beta-1a in the Treatment of Adult Patients with Secondary Progressive Multiple Sclerosis with Active Disease in Switzerland. PharmacoEconomics 39 (5) (2021)
Arjun Bhadhuri, Paul Kind, Paola Salari, Katharina Tabea Jungo, Benoît Boland, Stephen Byrne, Stefanie Hossmann, Olivia Dalleur, Wilma Knol, Elisavet Moutzouri, Denis O'Mahony, Kevin D Murphy, Linda Wisselink, Nicolas Rodondi, Matthias Schwenkglenks
Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy. Health and quality of life outcomes 18 (1) (2020)